European Urology

Papers
(The H4-Index of European Urology is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer1244
Manfred Wirth – A life devoted to urology in a time of change965
Editorial Board697
The Platinum Hall of Fame682
Honing Stratification and Treatment for High-risk Prostate Cancer636
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma501
Re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature 469
Editorial Board423
Re: The Prognostic Value of p53 and Ki-67 Expression Status in Penile Cancer: A Systematic Review and Meta-analysis289
Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0.289
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Tria270
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade252
Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901)241
Re: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis212
Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential201
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinica179
Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robot175
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial175
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. 2025;87:340–341174
Development and validation of a new personalized algorithmic model for PSA analysis : PROSTia165
18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging162
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study155
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy153
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2148
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update138
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder137
Acknowledgement to Reviewers133
Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Random132
Editorial Board128
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors123
Surgical and oncologic outcomes of surgery in early metastatic seminoma: Multi-institutional retrospective study121
Qualitative assessment of patient-reported outcomes in urinary and sexual function in patient after perineal urethrostomy121
Development of an individual postoperative prediction model for kidney cancer recurrence using machine learning (UroCCR study 120)117
Prenatal exposure to SSRI antidepressants and time of neonatal first void - A case control study112
MRI/US fusion targeted prostate biopsies koelis®: Impact of operator experience on clinicaly significant prostate cancer detection109
De-escalation of monitoring for prostate cancer active surveillance: Results of the GAP3 consortium102
Radiomics-based prognostic model guided by artificial intelligence to predict lymph node invasion and biochemical recurrence in patients with high-grade prostate cancer101
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials98
LEST: Anatomical ablative ejaculation sparing surgery for BPH97
Immunoprophyaxis with MV-140 is effective in the prevention of urinary tract infections – results of a prospective study97
Mechanism of cystine stone growth revealed by ultrastructural observation using scanning electron microscopy95
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma94
What are the optimal laser settings for stone dusting using the popcorn technique94
Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 89
Prostatectomy vs. radiotherapy for regional node positive prostate cancer88
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma87
Is testosterone replacement therapy effective and safe even for eugonadal men with symptom of late onset hypogonadism?87
Photodynamic diagnosis (PDD) directed biopsies vs white light bladder mapping in patients with positive cytology and negative preoperative workup: An international multicenter retrospective study. On 87
Erogenous and aversive sensation throughout the vulva, vagina, and breasts in cis-gender women: Anatomic heat-map to assess effect of treatment on erogenous sensation87
Assessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study85
Re-treatment for Lower Urinary Tract Symptoms (LUTS) after water vapor thermal therapy84
Reclassification of small renal masses according to the EAU Guidelines newly-proposed TNM classification for suspected renal cell carcinoma: Implications for decision-making83
More micrometastases, more recurrence? Assessing the role of quantitative rtPCR of PSA from lymph nodes post-prostatectomy in predicting biochemical recurrence - an experimental study83
Quantitative MRI parameters providing the novel value in discriminating muscle-invasive bladder cancer82
Incidental prostate cancer in patients treated for benign prostatic hyperplasia: Analysis from a contemporary national dataset82
Prognostic value of circulating tumor cells and cell-free DNA in upper tract urothelial carcinoma81
Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study80
Robot-assisted radical prostatectomy for prostate cancer: 18-year oncological outcomes from a Belgian high-volume center77
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?77
Transcriptomic analysis of the lncRNA-miRNA-mRNA axis network in aldosterone-producing adenoma76
Which men with cN1 prostate cancer at PSMA PET/CT represent the ideal candidate for radical prostatectomy? Development of a novel risk stratification tool for individualized approaches based on a larg76
100 years of history-making urology – the Portuguese urology association72
Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression71
A comprehensive in vitro assessment of thulium fiber laser in soft tissues and stones70
Outcomes of urethroplasty (UP), 10 years after surgery70
Fosfomycin for antibiotic prophylaxis in men undergoing a transrectal prostate biopsy: A systematic review and meta-analysis69
Minimally invasive cytoreductive nephrectomy for metastatic renal cell carcinoma in the immunotherapy era: Results from the REMARC-IO database68
0.048612117767334